Orgalutran - supply shortage

Resolved

ganirelix

Shortage information

The shortage affecting Orgalutran has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Orgalutran
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  ganirelix
• Therapeutic area (MESH):
  • Reproductive Techniques, Assisted
  • Ovulation Induction
  • Infertility, Female
• Pharmaceutical forms affected:
  Solution for injection in pre-filled pen
• Strengths affected:
  0.25 mg/0.5 ml
• Availability of alternatives:
  Yes

Key dates

• First published:
  16/02/2017
• Last updated:
  08/11/2022